The global Budesonide and Formoterol Fumarate market was valued at US$ 2500 million in 2025 and is anticipated to reach US$ 4007 million by 2032, at a CAGR of 6.8% from 2026 to 2032.

Budesonide and Formoterol Fumarate Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Budesonide and Formoterol Fumarate competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Budesonide and Formoterol Fumarate is a compound inhalation preparation consisting of budesonide, an inhaled corticosteroid, and formoterol, a long-acting β₂-adrenergic agonist. It exerts both anti-inflammatory and bronchodilator effects: budesonide reduces airway inflammation and hyperresponsiveness, while formoterol relaxes bronchial smooth muscle rapidly. It is mainly used for the long-term management and maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD), effectively relieving wheezing and dyspnea, and reducing the risk of acute exacerbations.In 2025, global Budesonide and Formoterol Fumarate production reached approximately 320 million units

Budesonide and formoterol is a core fixed-dose combination inhaled therapy for the global management of asthma and chronic obstructive pulmonary disease (COPD). With its dual mechanism of anti-inflammatory action and bronchodilation, it has long maintained a first-line clinical position. Historically dominated by originator brands, the global market has gradually diversified as patents expired and generic versions entered the market. Domestic and international generics have rapidly gained penetration through cost-effective advantages, driving higher overall market accessibility. On the demand side, rising global prevalence of chronic respiratory diseases, improved standardization of diagnosis and treatment, the implementation of tiered healthcare and chronic disease management policies, as well as consistent guideline recommendations for this combination therapy, collectively support steady market growth. At the same time, the sector faces challenges including intensified generic competition, pricing pressure, and patient share diversion from novel triple combinations and biological therapies. Overall, thanks to its well-established efficacy and broad indications, the product will continue to see stable market demand, with competition increasingly focusing on product quality, inhaler device optimization, cost control, and expansion in primary care and overseas markets.

This report delivers a comprehensive overview of the global Budesonide and Formoterol Fumarate market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Budesonide and Formoterol Fumarate. The Budesonide and Formoterol Fumarate market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Budesonide and Formoterol Fumarate market comprehensively. Regional market sizes by Type, by Application, by Dosage Form, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Budesonide and Formoterol Fumarate manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Budesonide and Formoterol Fumarate Market Report

Report Metric	Details
Report Name	Budesonide and Formoterol Fumarate Market
Accounted market size in 2025	US$ 2500 million
Forecasted market size in 2032	US$ 4007 million
CAGR	6.8%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	80/4.5 μg / inhalation 160/4.5 μg / inhalation
Segment by Dosage Form	Inhalation Powder Inhalation Aerosol
Segment by Production Technology	Innovator Generic
Segment by Sales Channels	Hospitals Retail Online
by Application	Asthma Chronic Obstructive Pulmonary Disease Airway Constriction Relief Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	AstraZeneca, Viatris, Teva, Sandoz, Chia Tai Tianqing Pharmaceutical, Joincare Pharmaceutical Group Industry, Lunan Pharmaceutical Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Dosage Form, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Budesonide and Formoterol Fumarate manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Budesonide and Formoterol Fumarate sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Budesonide and Formoterol Fumarate Market growing?

Ans: The Budesonide and Formoterol Fumarate Market witnessing a CAGR of 6.8% during the forecast period 2026-2032.

What is the Budesonide and Formoterol Fumarate Market size in 2032?

Ans: The Budesonide and Formoterol Fumarate Market size in 2032 will be US$ 4007 million.

Who are the main players in the Budesonide and Formoterol Fumarate Market report?

Ans: The main players in the Budesonide and Formoterol Fumarate Market are AstraZeneca, Viatris, Teva, Sandoz, Chia Tai Tianqing Pharmaceutical, Joincare Pharmaceutical Group Industry, Lunan Pharmaceutical Group

What are the Application segmentation covered in the Budesonide and Formoterol Fumarate Market report?

Ans: The Applications covered in the Budesonide and Formoterol Fumarate Market report are Asthma, Chronic Obstructive Pulmonary Disease, Airway Constriction Relief, Others

What are the Type segmentation covered in the Budesonide and Formoterol Fumarate Market report?

Ans: The Types covered in the Budesonide and Formoterol Fumarate Market report are 80/4.5 μg / inhalation, 160/4.5 μg / inhalation

1 Budesonide and Formoterol Fumarate Market Overview

1.1 Product Definition

1.2 Budesonide and Formoterol Fumarate by Type

1.2.1 Global Budesonide and Formoterol Fumarate Market Value by Type: 2025 vs 2032

1.2.2 80/4.5 μg / inhalation

1.2.3 160/4.5 μg / inhalation

1.3 Budesonide and Formoterol Fumarate by Dosage Form

1.3.1 Global Budesonide and Formoterol Fumarate Market Value by Dosage Form: 2025 vs 2032

1.3.2 Inhalation Powder

1.3.3 Inhalation Aerosol

1.4 Budesonide and Formoterol Fumarate by Production Technology

1.4.1 Global Budesonide and Formoterol Fumarate Market Value by Production Technology: 2025 vs 2032

1.4.2 Innovator

1.4.3 Generic

1.5 Budesonide and Formoterol Fumarate by Sales Channels

1.5.1 Global Budesonide and Formoterol Fumarate Market Value by Sales Channels: 2025 vs 2032

1.5.2 Hospitals

1.5.3 Retail

1.5.4 Online

1.6 Budesonide and Formoterol Fumarate by Application

1.6.1 Global Budesonide and Formoterol Fumarate Market Value by Application: 2025 vs 2032

1.6.2 Asthma

1.6.3 Chronic Obstructive Pulmonary Disease

1.6.4 Airway Constriction Relief

1.6.5 Others

1.7 Global Budesonide and Formoterol Fumarate Market Size Estimates and Forecasts

1.7.1 Global Budesonide and Formoterol Fumarate Revenue 2021–2032

1.7.2 Global Budesonide and Formoterol Fumarate Sales 2021–2032

1.7.3 Global Budesonide and Formoterol Fumarate Market Average Price (2021–2032)

1.8 Assumptions and Limitations

2 Budesonide and Formoterol Fumarate Market Competition by Manufacturers

2.1 Global Budesonide and Formoterol Fumarate Sales Market Share by Manufacturers (2021–2026)

2.2 Global Budesonide and Formoterol Fumarate Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Budesonide and Formoterol Fumarate Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Budesonide and Formoterol Fumarate, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Budesonide and Formoterol Fumarate, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Budesonide and Formoterol Fumarate, Product Types and Applications

2.7 Global Key Manufacturers of Budesonide and Formoterol Fumarate, Date of Entry into the Industry

2.8 Global Budesonide and Formoterol Fumarate Market Competitive Situation and Trends

2.8.1 Global Budesonide and Formoterol Fumarate Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Budesonide and Formoterol Fumarate Players Market Share by Revenue

2.8.3 Global Budesonide and Formoterol Fumarate Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Budesonide and Formoterol Fumarate Market Scenario by Region

3.1 Global Budesonide and Formoterol Fumarate Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Budesonide and Formoterol Fumarate Sales by Region: 2021–2032

3.2.1 Global Budesonide and Formoterol Fumarate Sales by Region: 2021–2026

3.2.2 Global Budesonide and Formoterol Fumarate Sales by Region: 2027–2032

3.3 Global Budesonide and Formoterol Fumarate Revenue by Region: 2021–2032

3.3.1 Global Budesonide and Formoterol Fumarate Revenue by Region: 2021–2026

3.3.2 Global Budesonide and Formoterol Fumarate Revenue by Region: 2027–2032

3.4 North America Budesonide and Formoterol Fumarate Market Facts & Figures by Country

3.4.1 North America Budesonide and Formoterol Fumarate Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Budesonide and Formoterol Fumarate Sales by Country (2021–2032)

3.4.3 North America Budesonide and Formoterol Fumarate Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Budesonide and Formoterol Fumarate Market Facts & Figures by Country

3.5.1 Europe Budesonide and Formoterol Fumarate Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Budesonide and Formoterol Fumarate Sales by Country (2021–2032)

3.5.3 Europe Budesonide and Formoterol Fumarate Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Budesonide and Formoterol Fumarate Market Facts & Figures by Region

3.6.1 Asia Pacific Budesonide and Formoterol Fumarate Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Budesonide and Formoterol Fumarate Sales by Region (2021–2032)

3.6.3 Asia Pacific Budesonide and Formoterol Fumarate Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Budesonide and Formoterol Fumarate Market Facts & Figures by Country

3.7.1 Latin America Budesonide and Formoterol Fumarate Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Budesonide and Formoterol Fumarate Sales by Country (2021–2032)

3.7.3 Latin America Budesonide and Formoterol Fumarate Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Budesonide and Formoterol Fumarate Market Facts & Figures by Country

3.8.1 Middle East and Africa Budesonide and Formoterol Fumarate Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Budesonide and Formoterol Fumarate Sales by Country (2021–2032)

3.8.3 Middle East and Africa Budesonide and Formoterol Fumarate Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Budesonide and Formoterol Fumarate Sales by Type (2021–2032)

4.1.1 Global Budesonide and Formoterol Fumarate Sales by Type (2021–2026)

4.1.2 Global Budesonide and Formoterol Fumarate Sales by Type (2027–2032)

4.1.3 Global Budesonide and Formoterol Fumarate Sales Market Share by Type (2021–2032)

4.2 Global Budesonide and Formoterol Fumarate Revenue by Type (2021–2032)

4.2.1 Global Budesonide and Formoterol Fumarate Revenue by Type (2021–2026)

4.2.2 Global Budesonide and Formoterol Fumarate Revenue by Type (2027–2032)

4.2.3 Global Budesonide and Formoterol Fumarate Revenue Market Share by Type (2021–2032)

4.3 Global Budesonide and Formoterol Fumarate Price by Type (2021–2032)

5 Segment by Application

5.1 Global Budesonide and Formoterol Fumarate Sales by Application (2021–2032)

5.1.1 Global Budesonide and Formoterol Fumarate Sales by Application (2021–2026)

5.1.2 Global Budesonide and Formoterol Fumarate Sales by Application (2027–2032)

5.1.3 Global Budesonide and Formoterol Fumarate Sales Market Share by Application (2021–2032)

5.2 Global Budesonide and Formoterol Fumarate Revenue by Application (2021–2032)

5.2.1 Global Budesonide and Formoterol Fumarate Revenue by Application (2021–2026)

5.2.2 Global Budesonide and Formoterol Fumarate Revenue by Application (2027–2032)

5.2.3 Global Budesonide and Formoterol Fumarate Revenue Market Share by Application (2021–2032)

5.3 Global Budesonide and Formoterol Fumarate Price by Application (2021–2032)

6 Key Companies Profiled

6.1 AstraZeneca

6.1.1 AstraZeneca Company Information

6.1.2 AstraZeneca Description and Business Overview

6.1.3 AstraZeneca Budesonide and Formoterol Fumarate Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 AstraZeneca Budesonide and Formoterol Fumarate Product Portfolio

6.1.5 AstraZeneca Recent Developments/Updates

6.2 Viatris

6.2.1 Viatris Company Information

6.2.2 Viatris Description and Business Overview

6.2.3 Viatris Budesonide and Formoterol Fumarate Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Viatris Budesonide and Formoterol Fumarate Product Portfolio

6.2.5 Viatris Recent Developments/Updates

6.3 Teva

6.3.1 Teva Company Information

6.3.2 Teva Description and Business Overview

6.3.3 Teva Budesonide and Formoterol Fumarate Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Teva Budesonide and Formoterol Fumarate Product Portfolio

6.3.5 Teva Recent Developments/Updates

6.4 Sandoz

6.4.1 Sandoz Company Information

6.4.2 Sandoz Description and Business Overview

6.4.3 Sandoz Budesonide and Formoterol Fumarate Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Sandoz Budesonide and Formoterol Fumarate Product Portfolio

6.4.5 Sandoz Recent Developments/Updates

6.5 Chia Tai Tianqing Pharmaceutical

6.5.1 Chia Tai Tianqing Pharmaceutical Company Information

6.5.2 Chia Tai Tianqing Pharmaceutical Description and Business Overview

6.5.3 Chia Tai Tianqing Pharmaceutical Budesonide and Formoterol Fumarate Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Chia Tai Tianqing Pharmaceutical Budesonide and Formoterol Fumarate Product Portfolio

6.5.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates

6.6 Joincare Pharmaceutical Group Industry

6.6.1 Joincare Pharmaceutical Group Industry Company Information

6.6.2 Joincare Pharmaceutical Group Industry Description and Business Overview

6.6.3 Joincare Pharmaceutical Group Industry Budesonide and Formoterol Fumarate Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Joincare Pharmaceutical Group Industry Budesonide and Formoterol Fumarate Product Portfolio

6.6.5 Joincare Pharmaceutical Group Industry Recent Developments/Updates

6.7 Lunan Pharmaceutical Group

6.7.1 Lunan Pharmaceutical Group Company Information

6.7.2 Lunan Pharmaceutical Group Description and Business Overview

6.7.3 Lunan Pharmaceutical Group Budesonide and Formoterol Fumarate Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Lunan Pharmaceutical Group Budesonide and Formoterol Fumarate Product Portfolio

6.7.5 Lunan Pharmaceutical Group Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Budesonide and Formoterol Fumarate Industry Chain Analysis

7.2 Budesonide and Formoterol Fumarate Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Budesonide and Formoterol Fumarate Production Mode & Process Analysis

7.4 Budesonide and Formoterol Fumarate Sales and Marketing

7.4.1 Budesonide and Formoterol Fumarate Sales Channels

7.4.2 Budesonide and Formoterol Fumarate Distributors

7.5 Budesonide and Formoterol Fumarate Customer Analysis

8 Budesonide and Formoterol Fumarate Market Dynamics

8.1 Budesonide and Formoterol Fumarate Industry Trends

8.2 Budesonide and Formoterol Fumarate Market Drivers

8.3 Budesonide and Formoterol Fumarate Market Challenges

8.4 Budesonide and Formoterol Fumarate Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Chia Tai-Tianqing Pharmaceutical

Joincare Pharmaceutical Group Industry

Lunan Pharmaceutical Group

List of Tables

Table 1. Global Budesonide and Formoterol Fumarate Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Budesonide and Formoterol Fumarate Market Value by Dosage Form (US$ Million), 2025 vs 2032

Table 3. Global Budesonide and Formoterol Fumarate Market Value by Production Technology (US$ Million), 2025 vs 2032

Table 4. Global Budesonide and Formoterol Fumarate Market Value by Sales Channels (US$ Million), 2025 vs 2032

Table 5. Global Budesonide and Formoterol Fumarate Market Value by Application (US$ Million), 2025 vs 2032

Table 6. Global Budesonide and Formoterol Fumarate Market Competitive Situation by Manufacturers in 2025

Table 7. Global Budesonide and Formoterol Fumarate Sales (Units) of Key Manufacturers (2021–2026)

Table 8. Global Budesonide and Formoterol Fumarate Sales Market Share by Manufacturers (2021–2026)

Table 9. Global Budesonide and Formoterol Fumarate Revenue (US$ Million) by Manufacturers (2021–2026)

Table 10. Global Budesonide and Formoterol Fumarate Revenue Share by Manufacturers (2021–2026)

Table 11. Global Market Budesonide and Formoterol Fumarate Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 12. Global Key Players of Budesonide and Formoterol Fumarate, Industry Ranking, 2023 vs 2024 vs 2025

Table 13. Global Key Manufacturers of Budesonide and Formoterol Fumarate, Manufacturing Sites and Headquarters

Table 14. Global Key Manufacturers of Budesonide and Formoterol Fumarate, Product Types and Applications

Table 15. Global Key Manufacturers of Budesonide and Formoterol Fumarate, Date of Entry into the Industry

Table 16. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Budesonide and Formoterol Fumarate Companies by Tier (Tier 1, Tier 2, Tier 3), based on Budesonide and Formoterol Fumarate Revenue, 2025

Table 18. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 19. Global Budesonide and Formoterol Fumarate Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 20. Global Budesonide and Formoterol Fumarate Sales by Region (Units), 2021–2026

Table 21. Global Budesonide and Formoterol Fumarate Sales Market Share by Region (2021–2026)

Table 22. Global Budesonide and Formoterol Fumarate Sales by Region (Units), 2027–2032

Table 23. Global Budesonide and Formoterol Fumarate Sales Market Share by Region (2027–2032)

Table 24. Global Budesonide and Formoterol Fumarate Revenue by Region (US$ Million), 2021–2026

Table 25. Global Budesonide and Formoterol Fumarate Revenue Market Share by Region (2021–2026)

Table 26. Global Budesonide and Formoterol Fumarate Revenue by Region (US$ Million), 2027–2032

Table 27. Global Budesonide and Formoterol Fumarate Revenue Market Share by Region (2027–2032)

Table 28. North America Budesonide and Formoterol Fumarate Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. North America Budesonide and Formoterol Fumarate Sales by Country (Units), 2021–2026

Table 30. North America Budesonide and Formoterol Fumarate Sales by Country (Units), 2027–2032

Table 31. North America Budesonide and Formoterol Fumarate Revenue by Country (US$ Million), 2021–2026

Table 32. North America Budesonide and Formoterol Fumarate Revenue by Country (US$ Million), 2027–2032

Table 33. Europe Budesonide and Formoterol Fumarate Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 34. Europe Budesonide and Formoterol Fumarate Sales by Country (Units), 2021–2026

Table 35. Europe Budesonide and Formoterol Fumarate Sales by Country (Units), 2027–2032

Table 36. Europe Budesonide and Formoterol Fumarate Revenue by Country (US$ Million), 2021–2026

Table 37. Europe Budesonide and Formoterol Fumarate Revenue by Country (US$ Million), 2027–2032

Table 38. Asia Pacific Budesonide and Formoterol Fumarate Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 39. Asia Pacific Budesonide and Formoterol Fumarate Sales by Region (Units), 2021–2026

Table 40. Asia Pacific Budesonide and Formoterol Fumarate Sales by Region (Units), 2027–2032

Table 41. Asia Pacific Budesonide and Formoterol Fumarate Revenue by Region (US$ Million), 2021–2026

Table 42. Asia Pacific Budesonide and Formoterol Fumarate Revenue by Region (US$ Million), 2027–2032

Table 43. Latin America Budesonide and Formoterol Fumarate Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 44. Latin America Budesonide and Formoterol Fumarate Sales by Country (Units), 2021–2026

Table 45. Latin America Budesonide and Formoterol Fumarate Sales by Country (Units), 2027–2032

Table 46. Latin America Budesonide and Formoterol Fumarate Revenue by Country (US$ Million), 2021–2026

Table 47. Latin America Budesonide and Formoterol Fumarate Revenue by Country (US$ Million), 2027–2032

Table 48. Middle East and Africa Budesonide and Formoterol Fumarate Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 49. Middle East and Africa Budesonide and Formoterol Fumarate Sales by Country (Units), 2021–2026

Table 50. Middle East and Africa Budesonide and Formoterol Fumarate Sales by Country (Units), 2027–2032

Table 51. Middle East and Africa Budesonide and Formoterol Fumarate Revenue by Country (US$ Million), 2021–2026

Table 52. Middle East and Africa Budesonide and Formoterol Fumarate Revenue by Country (US$ Million), 2027–2032

Table 53. Global Budesonide and Formoterol Fumarate Sales (Units) by Type (2021–2026)

Table 54. Global Budesonide and Formoterol Fumarate Sales (Units) by Type (2027–2032)

Table 55. Global Budesonide and Formoterol Fumarate Sales Market Share by Type (2021–2026)

Table 56. Global Budesonide and Formoterol Fumarate Sales Market Share by Type (2027–2032)

Table 57. Global Budesonide and Formoterol Fumarate Revenue (US$ Million) by Type (2021–2026)

Table 58. Global Budesonide and Formoterol Fumarate Revenue (US$ Million) by Type (2027–2032)

Table 59. Global Budesonide and Formoterol Fumarate Revenue Market Share by Type (2021–2026)

Table 60. Global Budesonide and Formoterol Fumarate Revenue Market Share by Type (2027–2032)

Table 61. Global Budesonide and Formoterol Fumarate Price (US$/Unit) by Type (2021–2026)

Table 62. Global Budesonide and Formoterol Fumarate Price (US$/Unit) by Type (2027–2032)

Table 63. Global Budesonide and Formoterol Fumarate Sales (Units) by Application (2021–2026)

Table 64. Global Budesonide and Formoterol Fumarate Sales (Units) by Application (2027–2032)

Table 65. Global Budesonide and Formoterol Fumarate Sales Market Share by Application (2021–2026)

Table 66. Global Budesonide and Formoterol Fumarate Sales Market Share by Application (2027–2032)

Table 67. Global Budesonide and Formoterol Fumarate Revenue (US$ Million) by Application (2021–2026)

Table 68. Global Budesonide and Formoterol Fumarate Revenue (US$ Million) by Application (2027–2032)

Table 69. Global Budesonide and Formoterol Fumarate Revenue Market Share by Application (2021–2026)

Table 70. Global Budesonide and Formoterol Fumarate Revenue Market Share by Application (2027–2032)

Table 71. Global Budesonide and Formoterol Fumarate Price (US$/Unit) by Application (2021–2026)

Table 72. Global Budesonide and Formoterol Fumarate Price (US$/Unit) by Application (2027–2032)

Table 73. AstraZeneca Company Information

Table 74. AstraZeneca Description and Business Overview

Table 75. AstraZeneca Budesonide and Formoterol Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 76. AstraZeneca Budesonide and Formoterol Fumarate Product

Table 77. AstraZeneca Recent Developments/Updates

Table 78. Viatris Company Information

Table 79. Viatris Description and Business Overview

Table 80. Viatris Budesonide and Formoterol Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 81. Viatris Budesonide and Formoterol Fumarate Product

Table 82. Viatris Recent Developments/Updates

Table 83. Teva Company Information

Table 84. Teva Description and Business Overview

Table 85. Teva Budesonide and Formoterol Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 86. Teva Budesonide and Formoterol Fumarate Product

Table 87. Teva Recent Developments/Updates

Table 88. Sandoz Company Information

Table 89. Sandoz Description and Business Overview

Table 90. Sandoz Budesonide and Formoterol Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 91. Sandoz Budesonide and Formoterol Fumarate Product

Table 92. Sandoz Recent Developments/Updates

Table 93. Chia Tai Tianqing Pharmaceutical Company Information

Table 94. Chia Tai Tianqing Pharmaceutical Description and Business Overview

Table 95. Chia Tai Tianqing Pharmaceutical Budesonide and Formoterol Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 96. Chia Tai Tianqing Pharmaceutical Budesonide and Formoterol Fumarate Product

Table 97. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates

Table 98. Joincare Pharmaceutical Group Industry Company Information

Table 99. Joincare Pharmaceutical Group Industry Description and Business Overview

Table 100. Joincare Pharmaceutical Group Industry Budesonide and Formoterol Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 101. Joincare Pharmaceutical Group Industry Budesonide and Formoterol Fumarate Product

Table 102. Joincare Pharmaceutical Group Industry Recent Developments/Updates

Table 103. Lunan Pharmaceutical Group Company Information

Table 104. Lunan Pharmaceutical Group Description and Business Overview

Table 105. Lunan Pharmaceutical Group Budesonide and Formoterol Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 106. Lunan Pharmaceutical Group Budesonide and Formoterol Fumarate Product

Table 107. Lunan Pharmaceutical Group Recent Developments/Updates

Table 108. Key Raw Materials Lists

Table 109. Raw Materials Key Suppliers Lists

Table 110. Budesonide and Formoterol Fumarate Distributors List

Table 111. Budesonide and Formoterol Fumarate Customers List

Table 112. Budesonide and Formoterol Fumarate Market Trends

Table 113. Budesonide and Formoterol Fumarate Market Drivers

Table 114. Budesonide and Formoterol Fumarate Market Challenges

Table 115. Budesonide and Formoterol Fumarate Market Restraints

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Product Picture of Budesonide and Formoterol Fumarate

Figure 2. Global Budesonide and Formoterol Fumarate Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Budesonide and Formoterol Fumarate Market Share by Type: 2025 & 2032

Figure 4. 80/4.5 μg / inhalation Product Picture

Figure 5. 160/4.5 μg / inhalation Product Picture

Figure 6. Global Budesonide and Formoterol Fumarate Market Value by Dosage Form (US$ Million), 2021–2032

Figure 7. Global Budesonide and Formoterol Fumarate Market Share by Dosage Form: 2025 vs 2032

Figure 8. Inhalation Powder Product Picture

Figure 9. Inhalation Aerosol Product Picture

Figure 10. Global Budesonide and Formoterol Fumarate Market Value by Production Technology (US$ Million), 2021–2032

Figure 11. Global Budesonide and Formoterol Fumarate Market Share by Production Technology: 2025 vs 2032

Figure 12. Innovator Product Picture

Figure 13. Generic Product Picture

Figure 14. Global Budesonide and Formoterol Fumarate Market Value by Sales Channels (US$ Million), 2021–2032

Figure 15. Global Budesonide and Formoterol Fumarate Market Share by Sales Channels: 2025 vs 2032

Figure 16. Hospitals Product Picture

Figure 17. Retail Product Picture

Figure 18. Online Product Picture

Figure 19. Global Budesonide and Formoterol Fumarate Market Value by Application (US$ Million), 2021–2032

Figure 20. Global Budesonide and Formoterol Fumarate Market Share by Application: 2025 & 2032

Figure 21. Asthma

Figure 22. Chronic Obstructive Pulmonary Disease

Figure 23. Airway Constriction Relief

Figure 24. Others

Figure 25. Global Budesonide and Formoterol Fumarate Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 26. Global Budesonide and Formoterol Fumarate Market Size (US$ Million), 2021–2032

Figure 27. Global Budesonide and Formoterol Fumarate Sales (Units), 2021–2032

Figure 28. Global Budesonide and Formoterol Fumarate Average Price (US$/Unit), 2021–2032

Figure 29. Budesonide and Formoterol Fumarate Report Years Considered

Figure 30. Budesonide and Formoterol Fumarate Sales Share by Manufacturers in 2025

Figure 31. Global Budesonide and Formoterol Fumarate Revenue Share by Manufacturers in 2025

Figure 32. Top 5 and Top 10 Global Budesonide and Formoterol Fumarate Players: Market Share by Revenue in Budesonide and Formoterol Fumarate in 2025

Figure 33. Budesonide and Formoterol Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 34. Global Budesonide and Formoterol Fumarate Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 35. North America Budesonide and Formoterol Fumarate Sales Market Share by Country (2021–2032)

Figure 36. North America Budesonide and Formoterol Fumarate Revenue Market Share by Country (2021–2032)

Figure 37. United States Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. Canada Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Europe Budesonide and Formoterol Fumarate Sales Market Share by Country (2021–2032)

Figure 40. Europe Budesonide and Formoterol Fumarate Revenue Market Share by Country (2021–2032)

Figure 41. Germany Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. France Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. U.K. Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Italy Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Russia Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Asia Pacific Budesonide and Formoterol Fumarate Sales Market Share by Region (2021–2032)

Figure 47. Asia Pacific Budesonide and Formoterol Fumarate Revenue Market Share by Region (2021–2032)

Figure 48. China Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Japan Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. South Korea Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. India Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Australia Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. China Taiwan Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Southeast Asia Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Latin America Budesonide and Formoterol Fumarate Sales Market Share by Country (2021–2032)

Figure 56. Latin America Budesonide and Formoterol Fumarate Revenue Market Share by Country (2021–2032)

Figure 57. Mexico Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032

Figure 58. Brazil Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032

Figure 59. Argentina Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032

Figure 60. Colombia Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032

Figure 61. Middle East and Africa Budesonide and Formoterol Fumarate Sales Market Share by Country (2021–2032)

Figure 62. Middle East and Africa Budesonide and Formoterol Fumarate Revenue Market Share by Country (2021–2032)

Figure 63. Turkey Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032

Figure 64. Saudi Arabia Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032

Figure 65. UAE Budesonide and Formoterol Fumarate Revenue Growth Rate (US$ Million), 2021–2032

Figure 66. Global Sales Market Share of Budesonide and Formoterol Fumarate by Type (2021–2032)

Figure 67. Global Revenue Market Share of Budesonide and Formoterol Fumarate by Type (2021–2032)

Figure 68. Global Budesonide and Formoterol Fumarate Price (US$/Unit) by Type (2021–2032)

Figure 69. Global Sales Market Share of Budesonide and Formoterol Fumarate by Application (2021–2032)

Figure 70. Global Revenue Market Share of Budesonide and Formoterol Fumarate by Application (2021–2032)

Figure 71. Global Budesonide and Formoterol Fumarate Price (US$/Unit) by Application (2021–2032)

Figure 72. Budesonide and Formoterol Fumarate Value Chain

Figure 73. Channels of Distribution (Direct Vs Distribution)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions